Universitätsklinikum Augsburg

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4 (2021) Kayser S, Martinez-Cuadron D, Hanoun M, Stoelzel F, Gil C, Reinhardt HC, Aguiar E, et al. Conference contribution Allogeneic Hematopoietic Cell Transplantation in Patients <= 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial- (2021) Bornhaeuser M, Schliemann C, Schetelig J, Rollig C, Kramer M, Glass B, Platzbecker U, et al. Conference contribution Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute BLymphoblastic Leukemia (INITIAL-1 trial) (2021) Stelljes M, Alakel N, Waesch R, Scholl S, Nachtkamp K, Rank A, Haenel M, et al. Conference contribution Emergency Use of Convalescent Plasma: Perception of the Regulatory Framework from a Clinical Perspective (2021) Mohnle P, Humpe A, Boeck M, Gruetzner S, Hackstein H, Offner R, Hildebrandt M Journal article, Review article Continued versus interrupted targeted therapy during metastasis‐directed stereotactic radiotherapy: A retrospective multi‐center safety and efficacy analysis (2021) Kroeze SGC, Fritz C, Schaule J, Blanck O, Kahl KH, Kaul D, Siva S, et al. Journal article Vaccine-Induced Thrombocytopenia with Severe Headache (2021) Salih F, Schoenborn L, Kohler S, Franke C, Moeckel M, Doerner T, Bauknecht HC, et al. Journal article, Letter Melanoma in Pregnancy: CLAUDIUS - a retrospective, multicenter Study to evaluate the Risk of transplacental Transmission to the unborn Child (2021) Gaiser MR, Mueller V, Erdmann M, Buehler B, Dugas-Breit S, Schatton K, Reinhardt L, et al. Conference contribution CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma (2021) Klümper N, Ralser DJ, Zarbl R, Schlack K, Schrader AJ, Rehlinghaus M, Hoffmann MJ, et al. Journal article Comprehensive Immunohistochemical Study of the SWI/SNF Complex Expression Status in Gastric Cancer Reveals an Adverse Prognosis of SWI/SNF Deficiency in Genomically Stable Gastric Carcinomas (2021) Glueckstein MI, Dintner S, Arndt TT, Vlasenko D, Schenkirsch G, Agaimy A, Mueller G, et al. Journal article Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial (2021) Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, et al. Journal article